Skip to content
Y-mAbs Therapeutics, Inc. Logo
  • About us
    • Overview
    • Leadership
    • Contact
  • Our Portfolio
    • Radiopharmaceuticals
    • Pipeline
    • Naxitamab
    • Pipeline
    • Scientific resources
  • DANYELZA®
  • Partnerships
  • Resources
    • Overview
    • Patients & caregivers
    • Physicians
    • ISS Grant Submission
  • Investors
    • Investor Overview
    • News & Events
    • News Releases
    • Events & Presentations
    • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
    • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Careers
Y-mAbs Therapeutics, Inc. Logo
Y-mAbs Therapeutics, Inc. Logo
  • About us
    • Overview
    • Leadership
    • Contact
  • Our Portfolio
    • Radiopharmaceuticals
    • Pipeline
    • Naxitamab
    • Pipeline
    • Scientific resources
  • DANYELZA®
  • Partnerships
  • Resources
    • Overview
    • Patients & caregivers
    • Physicians
    • ISS Grant Submission
  • Investors
    • Investor Overview
    • News & Events
    • News Releases
    • Events & Presentations
    • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
    • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Careers
Y-mAbs Therapeutics, Inc. Logo

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 04, 2025
Document Date
Mar 04, 2025
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
  • About us
    • Overview
    • Leadership
    • Contact
  • Our Portfolio
    • Radiopharmaceuticals
    • Pipeline
    • Naxitamab
    • Pipeline
    • Scientific resources
  • DANYELZA®
  • Partnerships
  • Resources
    • Overview
    • Patients & caregivers
    • Physicians
    • ISS Grant Submission
  • Investors
    • Investor Overview
    • News & Events
    • News Releases
    • Events & Presentations
    • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
    • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Leadership
    • Committee Composition
    • Financial Information
    • SEC Filings
    • Annual Reports
    • Quarterly Results
    • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Careers

Y-mAbs Therapeutics, Inc. Logo

Company

  • About Us
  • Leadership
  • Culture of Integrity
  • Community Guidelines
  • Careers
  • Contact

Science

  • Radiopharmaceuticals
  • Naxitamab
  • DANYELZA®
  • Partnerships
  • Scientific Resources

Support

  • ISS Grant Submission
  • Resources
  • Patients & Caregivers
  • Physicians

Investors

  • Overview
  • Stock Information
  • News & Presentations
  • Financial Information
  • Corporate Governance
  • Investor Resources
  • Accessibility
  • Cookie Policy
  • Privacy Statement
  • Terms of Use

Copyright © 2025 Y-mAbs Therapeutics, Inc. All rights reserved. CRP-000001 03/2024

Scroll to Top